|Articles|August 1, 2016
- Pharmaceutical Executive-08-01-2016
- Volume 36
- Issue 8
Pharmaceutical Executive, August 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Pharm Exec's 15th Annual Industry Auditabout 10 years ago
The Industry Audit: Fifteen Years Rightabout 10 years ago
Dealmaking in 2016: It’s Complicatedabout 10 years ago
Steady Hands: AmerisourceBergen's Peyton Howellabout 10 years ago
Drug Shortages Raise Economic and Ethical Challengesabout 10 years ago
The ‘Cure’-All for 21st Century Data Sharingabout 10 years ago
European Pharma and the Unified Patent Courtabout 10 years ago
An EU Referendum ... on Drug Pricing?about 10 years ago
Country Report: HungaryAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
340B Under Pressure: Inside Pharma's Push for Greater Clarity
3
The Agentic AI Revolution in Biopharma
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5